The Brookbush Institute continues to enhance education with new articles, new courses, a modern glossary, an AI Tutor, ...

As men get older, it’s common to notice changes when going to the bathroom. If you feel like you can’t fully empty your bladder, you have a weak urine stream, or you’re waking up often at night to use ...

The treatments for both classic and nonclassic congenital adrenal hyperplasia (CAH) include medication, surgery, and psychological support, or a combination of all three. Some people who have CAH, ...

Congenital adrenal hyperplasia (CAH) is a group of inherited conditions in which the adrenal glands cannot make certain hormones, most commonly due to a deficiency of the enzyme 21-hydroxylase. This ...

Management of classic congenital adrenal hyperplasia (CAH), a rare genetic condition diagnosed at birth, requires a careful balance between androgen and cortisol. Most often caused by a genetic ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. Disease control and reduced glucocorticoid doses ...

Cochrane authors investigated the efficacy and safety of oral and intrauterine progestogens for the precancerous condition of thickening in the lining of the womb (endometrium) called atypical ...

Orlando, Florida — New data add to the evidence supporting use of crinecerfont for the treatment of congenital adrenal hyperplasia (CAH) due to 21-hydroxylase deficiency, in both adults and children.

Men with benign prostatic hyperplasia (BPH) appear to have higher risks for chronic kidney disease (CKD) and kidney stones. Men with benign prostatic hyperplasia (BPH) are at increased risk for ...

‌Sebaceous hyperplasia is a harmless, common skin condition that becomes more common with age. It happens when your sebaceous oil glands make too much oil that gets trapped under your skin and causes ...

The FDA approved crinecerfont (Crenessity) as a first-in-class treatment for classic congenital adrenal hyperplasia (CAH), the agency announced late Friday. Crinecerfont was approved for use in ...

Crenessity is expected to be available commercially in approximately 1 week through PANTHERx Rare, a specialty pharmacy. The Food and Drug Administration (FDA) has approved Crenessity TM (crinecerfont ...